Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

Results: 1 to 20 of 169

1.
2.

Study of the use of antidepressants for depression in dementia: the HTA-SADD trial--a multicentre, randomised, double-blind, placebo-controlled trial of the clinical effectiveness and cost-effectiveness of sertraline and mirtazapine.

Banerjee S, Hellier J, Romeo R, Dewey M, Knapp M, Ballard C, Baldwin R, Bentham P, Fox C, Holmes C, Katona C, Lawton C, Lindesay J, Livingston G, McCrae N, Moniz-Cook E, Murray J, Nurock S, Orrell M, O'Brien J, Poppe M, Thomas A, Walwyn R, Wilson K, Burns A.

Health Technol Assess. 2013 Feb;17(7):1-166. doi: 10.3310/hta17070.

PMID:
23438937
[PubMed - indexed for MEDLINE]
Free Article
3.

Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial.

Banerjee S, Hellier J, Dewey M, Romeo R, Ballard C, Baldwin R, Bentham P, Fox C, Holmes C, Katona C, Knapp M, Lawton C, Lindesay J, Livingston G, McCrae N, Moniz-Cook E, Murray J, Nurock S, Orrell M, O'Brien J, Poppe M, Thomas A, Walwyn R, Wilson K, Burns A.

Lancet. 2011 Jul 30;378(9789):403-11. doi: 10.1016/S0140-6736(11)60830-1. Epub 2011 Jul 19. Review.

PMID:
21764118
[PubMed - indexed for MEDLINE]
4.

A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.

Tariot PN, Cummings JL, Katz IR, Mintzer J, Perdomo CA, Schwam EM, Whalen E.

J Am Geriatr Soc. 2001 Dec;49(12):1590-9.

PMID:
11843990
[PubMed - indexed for MEDLINE]
5.
6.

A randomised, blinded, placebo-controlled trial in dementia patients continuing or stopping neuroleptics (the DART-AD trial).

Ballard C, Lana MM, Theodoulou M, Douglas S, McShane R, Jacoby R, Kossakowski K, Yu LM, Juszczak E; Investigators DART AD.

PLoS Med. 2008 Apr 1;5(4):e76. doi: 10.1371/journal.pmed.0050076.

PMID:
18384230
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Cost-effectiveness analyses for mirtazapine and sertraline in dementia: randomised controlled trial.

Romeo R, Knapp M, Hellier J, Dewey M, Ballard C, Baldwin R, Bentham P, Burns A, Fox C, Holmes C, Katona C, Lawton C, Lindesay J, Livingston G, McCrae N, Moniz-Cook E, Murray J, Nurock S, O'Brien J, Poppe M, Thomas A, Walwyn R, Wilson K, Banerjee S.

Br J Psychiatry. 2013 Feb;202:121-8. doi: 10.1192/bjp.bp.112.115212. Epub 2012 Dec 20.

PMID:
23258767
[PubMed - indexed for MEDLINE]
Free Article
8.

[Use of antidepressant drugs in schizophrenic patients with depression].

Micallef J, Fakra E, Blin O.

Encephale. 2006 Mar-Apr;32(2 Pt 1):263-9. Review. French.

PMID:
16910628
[PubMed - indexed for MEDLINE]
9.

Randomised controlled trial to determine the clinical effectiveness and cost-effectiveness of selective serotonin reuptake inhibitors plus supportive care, versus supportive care alone, for mild to moderate depression with somatic symptoms in primary care: the THREAD (THREshold for AntiDepressant response) study.

Kendrick T, Chatwin J, Dowrick C, Tylee A, Morriss R, Peveler R, Leese M, McCrone P, Harris T, Moore M, Byng R, Brown G, Barthel S, Mander H, Ring A, Kelly V, Wallace V, Gabbay M, Craig T, Mann A.

Health Technol Assess. 2009 Apr;13(22):iii-iv, ix-xi, 1-159. doi: 10.3310/hta13220.

PMID:
19401066
[PubMed - indexed for MEDLINE]
Free Article
10.

Treating depression in Alzheimer disease: efficacy and safety of sertraline therapy, and the benefits of depression reduction: the DIADS.

Lyketsos CG, DelCampo L, Steinberg M, Miles Q, Steele CD, Munro C, Baker AS, Sheppard JM, Frangakis C, Brandt J, Rabins PV.

Arch Gen Psychiatry. 2003 Jul;60(7):737-46.

PMID:
12860778
[PubMed - indexed for MEDLINE]
11.

Randomized controlled trial of different models of care for nursing home residents with dementia complicated by depression or psychosis.

Brodaty H, Draper BM, Millar J, Low LF, Lie D, Sharah S, Paton H.

J Clin Psychiatry. 2003 Jan;64(1):63-72.

PMID:
12590626
[PubMed - indexed for MEDLINE]
12.

Open-label treatment with desvenlafaxine in postmenopausal women with major depressive disorder not responding to acute treatment with desvenlafaxine or escitalopram.

Soares CN, Thase ME, Clayton A, Guico-Pabia CJ, Focht K, Jiang Q, Kornstein SG, Ninan PT, Kane CP.

CNS Drugs. 2011 Mar;25(3):227-38. doi: 10.2165/11586460-000000000-00000.

PMID:
21323394
[PubMed - indexed for MEDLINE]
13.

A 3-month, randomized, placebo-controlled, neuroleptic discontinuation study in 100 people with dementia: the neuropsychiatric inventory median cutoff is a predictor of clinical outcome.

Ballard CG, Thomas A, Fossey J, Lee L, Jacoby R, Lana MM, Bannister C, McShane R, Swann A, Juszczak E, O'Brien JT.

J Clin Psychiatry. 2004 Jan;65(1):114-9.

PMID:
14744180
[PubMed - indexed for MEDLINE]
14.

Sertraline for the treatment of depression in Alzheimer disease: week-24 outcomes.

Weintraub D, Rosenberg PB, Drye LT, Martin BK, Frangakis C, Mintzer JE, Porsteinsson AP, Schneider LS, Rabins PV, Munro CA, Meinert CL, Lyketsos CG; DIADS-2 Research Group.

Am J Geriatr Psychiatry. 2010 Apr;18(4):332-40. doi: 10.1097/JGP.0b013e3181cc0333.

PMID:
20220589
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

The efficacy of ginkgo for elderly people with dementia and age-associated memory impairment: new results of a randomized clinical trial.

van Dongen MC, van Rossum E, Kessels AG, Sielhorst HJ, Knipschild PG.

J Am Geriatr Soc. 2000 Oct;48(10):1183-94.

PMID:
11037003
[PubMed - indexed for MEDLINE]
16.

A randomized controlled trial of duloxetine versus placebo in the treatment of nonmajor chronic depression.

Hellerstein DJ, Stewart JW, McGrath PJ, Deliyannides DA, Batchelder ST, Black SR, Withers A, O'Shea D, Chen Y.

J Clin Psychiatry. 2012 Jul;73(7):984-91. doi: 10.4088/JCP.11m07230.

PMID:
22901348
[PubMed - indexed for MEDLINE]
17.

Effectiveness of collaborative care for older adults with Alzheimer disease in primary care: a randomized controlled trial.

Callahan CM, Boustani MA, Unverzagt FW, Austrom MG, Damush TM, Perkins AJ, Fultz BA, Hui SL, Counsell SR, Hendrie HC.

JAMA. 2006 May 10;295(18):2148-57.

PMID:
16684985
[PubMed - indexed for MEDLINE]
18.

Desvenlafaxine 50 and 100 mg/d in the treatment of major depressive disorder: an 8-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial and a post hoc pooled analysis of three studies.

Tourian KA, Padmanabhan SK, Groark J, Brisard C, Farrington D.

Clin Ther. 2009 Jun;31 Pt 1:1405-23. doi: 10.1016/j.clinthera.2009.07.006.

PMID:
19698901
[PubMed - indexed for MEDLINE]
19.

Treatment of dysthymia and minor depression in primary care: A randomized controlled trial in older adults.

Williams JW Jr, Barrett J, Oxman T, Frank E, Katon W, Sullivan M, Cornell J, Sengupta A.

JAMA. 2000 Sep 27;284(12):1519-26.

PMID:
11000645
[PubMed - indexed for MEDLINE]
20.

Effect of sertraline on symptoms and survival in patients with advanced cancer, but without major depression: a placebo-controlled double-blind randomised trial.

Stockler MR, O'Connell R, Nowak AK, Goldstein D, Turner J, Wilcken NR, Wyld D, Abdi EA, Glasgow A, Beale PJ, Jefford M, Dhillon H, Heritier S, Carter C, Hickie IB, Simes RJ; Zoloft's Effects on Symptoms and survival Time Trial Group.

Lancet Oncol. 2007 Jul;8(7):603-12. Erratum in: Lancet Oncol. 2007 Jul 8;8(7):574.

PMID:
17548243
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk